Press release
The Biopharmaceutical Excipients Market to Reach $3.79 Billion by 2029, Merck KGaA, BASF SE, Avantor, & Evonik Industries AG are the Major Stakeholders - Arizton
Global Biopharmaceutical Excipients Market - Focused Insights 2024-2029
Curious to Know More About the Market? Click: https://www.arizton.com/market-reports/biopharmaceutical-excipients-market
Report Scope
Market Size (2029): $3.79 Billion
Market Size (2023): $2.43 Billion
CAGR (2023-2029): 7.67%
Historic Year: 2020-2022
Base Year: 2023
Forecast Year: 2024-2029
Market Segmentation: Excipient, Biologics, Scale of Operations, Origin, End-Users, and Geography
Stay ahead of the curve with Arizton's exclusive subscription plan, offering in-depth analysis, market sizing, and growth forecasts for less than $900 per month-a significant value compared to individual report purchases. Click here: https://www.arizton.com/subscription
The increasing demand for biopharmaceuticals is significantly driving the need for excipients in the production of biological drugs. As cancer and infectious diseases become more prevalent, there is a heightened need for vaccines, monoclonal antibodies, and other therapeutic solutions. Additionally, advances in various therapies are fueling the need for innovative and multifunctional excipients.
Growth of CMOs & CDMOs Segment
The CMOs (Contract Manufacturing Organizations) and CDMOs (Contract Development and Manufacturing Organizations) segment is experiencing notable growth, demonstrating the highest CAGR during the forecast period. Biopharmaceuticals, with their large molecular sizes and complex manufacturing processes, differ significantly from traditional small molecule drugs regarding behavior, production methods, and therapeutic effects. The complexities of biopharmaceutical manufacturing have led many biopharma companies to increasingly depend on CMOs and CDMOs for their specialized expertise and advanced capabilities.
Outsourcing to CMOs and CDMOs has become a preferred strategy among biopharma companies, as these organizations provide the specialized knowledge and infrastructure needed for efficient production. This allows biopharma developers to focus on product commercialization and clinical development while leveraging the manufacturing expertise of CMOs and CDMOs. The growing reliance on outsourcing and the expansion of new and existing product lines-including clinical trial supply services-has significantly contributed to the steady rise in CMO and CDMO sales.
Competitive Overview
The global biopharmaceutical excipients market report features data on 36 vendors, highlighting the diverse landscape of players ranging from emerging mid-sized companies to established industry leaders. Leading companies are employing a range of strategies to boost their market share and enhance their presence. These strategies include launching new products, securing regulatory approvals, engaging in marketing and promotional efforts, investing significantly in research and development, and strengthening distribution networks.
Significant players like Merck KGaA, BASF SE, Avantor, Evonik Industries, Roquette Freres, and Associated British Foods actively pursue strategic initiatives such as licensing agreements, acquisitions, and collaborations with emerging firms. These efforts enable them to rapidly enter the biopharmaceutical excipients market and gain access to commercially viable products. Companies also focus on expanding into existing and new markets to cater to a growing customer base, broadening their product portfolios, and enhancing production capabilities.
Additionally, there is a push towards introducing advanced and novel excipient solutions to support pharmaceutical drug development, alongside ensuring robust distribution chains to meet evolving market demands.
Buy this Research Now @ https://www.arizton.com/market-reports/biopharmaceutical-excipients-market
Key Vendors
*
Merck KGaA
*
BASF SE
*
Avantor
*
Evonik Industries AG
*
Roquette Freres
*
Associated British Foods plc
*
Actylis
*
Advancion
*
Apothecon Pharmaceuticals
*
Ashland
*
BioSpectra
*
BOC Sciences
*
CG Group
*
Clariant
*
Colorcon
*
DFE Pharma
*
Dow
*
Eastman Chemical Company
*
IMCD
*
Innophos
*
InVitria
*
ABITEC
*
CordenPharma
*
Croda International plc
*
JRS Pharma
*
Kirsch Pharma
*
MEGGLE
*
Novo Nordisk
*
Pfanstiehl
*
Shin-Etsu Chemical
*
Sigachi Industries
*
Spectrum Chemical
*
Stepan Company
*
Tereos
*
The Lubrizol Corporation
*
WACKER CHEMI
Segmentation & Forecast
Excipient
*
Bulking Agents
*
Solubilizers & Surfactants
*
Buffering & Tonicity Agents
*
Others
Biologics
*
Monoclonal Antibodies
*
Vaccines
*
Others
Scale of Operation
*
Commercial
*
Research
Origin
*
Organic Excipients
*
Inorganic Excipients
End-User
*
Pharma & Biotech Companies
*
CMOs & CDMOs
*
Academic & Research Institutes
Geography
*
North America
*
The U.S.
*
Canada
*
Europe
*
Germany
*
The U.K.
*
France
*
Italy
*
Spain
*
APAC
*
Japan
*
China
*
India
*
Australia
*
South Korea
*
Latin America
*
Brazil
*
Mexico
*
Argentina
*
Middle East & Africa
*
Turkey
*
South Africa
*
Saudi Arabia
Key Questions Answered in the Report:
How big is the global biopharmaceutical excipients market?
What is the growth rate of the global biopharmaceutical excipients market?
What are the key trends in the global biopharmaceutical excipients market?
Which region shows the highest growth in the global biopharmaceutical excipients market?
Who are the major players in the global biopharmaceutical excipients market?
Check Out Some of the Top Selling Research Reports:
IVD Contract Manufacturing Market - Global Outlook & Forecast 2024-2029
https://www.arizton.com/market-reports/ivd-contract-manufacturing-market
Europe Clinical Laboratory Tests Market - Focused Insights 2024-2029
https://www.arizton.com/market-reports/europe-clinical-laboratory-tests-market
Why Arizton?
100%Customer Satisfaction
24x7availability - we are always there when you need us
200+Fortune 500 Companies trust Arizton's report
80%of our reports are exclusive and first in the industry
100%more data and analysis
1500+reports published till date
Post-Purchase Benefit
*
1hr of free analyst discussion
*
10% off on customization
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=the-biopharmaceutical-excipients-market-to-reach-379-billion-by-2029-merck-kgaa-basf-se-avantor-evonik-industries-ag-are-the-major-stakeholders-arizton]
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/biopharmaceutical-excipients-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Biopharmaceutical Excipients Market to Reach $3.79 Billion by 2029, Merck KGaA, BASF SE, Avantor, & Evonik Industries AG are the Major Stakeholders - Arizton here
News-ID: 3614623 • Views: …
More Releases from ABNewswire
98% Consistency, 0 Staff: Anno Robot Redefines Airport Coffee in 60 Countries
As millions of travellers rush through terminals worldwide, one constant complaint has finally been solved: bad airport coffee served slowly by exhausted staff. Shenzhen-based Anno Robot [https://www.coffeerobotsanno.com/] has quietly eliminated both problems with fully robotic kiosks that deliver 98% brew-to-brew consistency and require zero human baristas. By November 2025, these AI-powered stations are operating in airports and high-traffic hubs across more than 60 countries, marking a turning point for the…
FAXVIN Unveils Enhanced CarRank, a 0-100 Single-Score Summary That Makes Used-Ca …
Updated methodology brings additional partner data and refined signal weighting so shoppers and dealers can rank and compare vehicles in seconds.
WALNUT, Calif. - Nov. 19, 2025 - FAXVIN today announced a significant update to CarRank, its 0-100 vehicle-history metric designed to help shoppers and dealers compare used cars at a glance. The latest release incorporates additional data sources and methodology refinements that improve how risk signals are weighted across title…
Global Pro AV Market Surges Toward USD 127.31 Billion by 2030, Led by Sony, Sams …
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025-2030.
According to Arizton research, the global pro AV market [https://www.arizton.com/market-reports/pro-av-market] was valued at USD 90.00 billion in 2024 and is projected to reach USD 127.31 billion by 2030, growing at a CAGR of 5.95% during the forecast period.
Explore the Full Market Insights: https://www.arizton.com/market-reports/pro-av-market
Report Summary:
Market Size (2030): USD 127.31 Billion
Market Size (2024): USD 90.00 Billion
CAGR (2024-2030): 5.95%
Historic…
Redway Power Launches High-Capacity 51.2V 420Ah Lithium Forklift Battery for Nex …
Redway Power, a leading OEM lithium battery manufacturer, proudly announces the launch of its latest innovation: the 51.2V 420Ah Lithium Forklift Battery [https://www.redwaypower.com/product/48v-420ah-forklift-lithium-battery/]. Designed for modern industrial operations, this next-generation battery combines high capacity, advanced safety features, and customizable OEM/ODM solutions to revolutionize warehouse productivity and material handling efficiency.
Introducing Next-Generation Power for Forklifts
The new 51.2V 420Ah battery is engineered to deliver exceptional energy efficiency and durability. With a nominal energy…
More Releases for Excipient
Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Albumin Excipient Market Size Growth Forecast: What to Expect by 2025?
The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of…
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater…
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market…
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197
Market Analysis:
Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical…
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,…
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027.
The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and…
